CYTOMEGALOVIRUS PNEUMONIA IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN IMMUNOPATHOLOGIC PROCESS

被引:27
作者
CHIEN, J
CHAN, CK
CHAMBERLAIN, D
PATTERSON, B
FYLES, G
MINDEN, M
MEHARCHAND, J
MESSNER, H
机构
[1] WELLESLEY COLL HOSP,DEPT PATHOL,160 WELLESLEY ST E,TORONTO M4Y LJ3,ONTARIO,CANADA
[2] PRINCESS MARGARET HOSP,DEPT MED,TORONTO M4X 1K9,ONTARIO,CANADA
[3] WELLESLEY COLL HOSP,DEPT MED,TORONTO,ONTARIO,CANADA
[4] PRINCESS MARGARET HOSP,DEPT PATHOL,TORONTO M4X 1K9,ONTARIO,CANADA
[5] TORONTO GEN HOSP,DEPT PATHOL,TORONTO M5G 1L7,ONTARIO,CANADA
关键词
D O I
10.1378/chest.98.4.1034
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Recent literature suggests that CMV pneumonia is an immunopathologic process. This case report summarizes the clinical course of a patient which supports this hypothesis. The patient is the recipient of an allogeneic BMT who recovered from an episode of CMV pneumonia that occurred about two months after the transplant. Despite recovery from the viral infection, follow-up BALs revealed persistent lymphocytosis in an apparent asymptomatic patient. He subsequently developed BOOP about four months after the initial CMV infection. These observations suggest that the viral infection may have resulted in the activation of the host's cell-mediated response and provides evidence to support the hypothesis that CMV pneumonia is an immune-mediated process.
引用
收藏
页码:1034 / 1037
页数:4
相关论文
共 7 条
  • [1] CHAN CK, 1987, MEDICINE, V66, P324
  • [2] CYTOMEGALO-VIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION SUCCESSFULLY TREATED WITH THE COMBINATION OF GANCICLOVIR AND HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN
    EMANUEL, D
    CUNNINGHAM, I
    JULESELYSEE, K
    BROCHSTEIN, JA
    KERNAN, NA
    LAVER, J
    STOVER, D
    WHITE, DA
    FELS, A
    POLSKY, B
    CASTROMALASPINA, H
    PEPPARD, JR
    BARTUS, P
    HAMMERLING, U
    OREILLY, RJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) : 777 - 782
  • [3] BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA
    EPLER, GR
    COLBY, TV
    MCLOUD, TC
    CARRINGTON, CB
    GAENSLER, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) : 152 - 158
  • [4] GRUNDY JE, 1987, LANCET, V2, P996
  • [5] RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION AFTER HUMAN MARROW TRANSPLANTATION
    MEYERS, JD
    FLOURNOY, N
    THOMAS, ED
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) : 478 - 488
  • [6] TREATMENT OF CYTOMEGALO-VIRUS PNEUMONIA WITH GANCICLOVIR AND INTRAVENOUS CYTOMEGALO-VIRUS IMMUNOGLOBULIN IN PATIENTS WITH BONE-MARROW TRANSPLANTS
    REED, EC
    BOWDEN, RA
    DANDLIKER, PS
    LILLEBY, KE
    MEYERS, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) : 783 - 788
  • [7] ACTIVITY OF 9-[2-HYDROXY-1-(HYDROXYMETHYL)ETHOXYMETHYL]GUANINE IN THE TREATMENT OF CYTOMEGALO-VIRUS PNEUMONIA
    SHEPP, DH
    DANDLIKER, PS
    DEMIRANDA, P
    BURNETTE, TC
    CEDERBERG, DM
    KIRK, LE
    MEYERS, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) : 368 - 373